IDEX Competitors

Delisted . USA . 
Stock . IDEX Biometrics ASA
IDXAFDelisted Stock  USD 0.17  0.00  0.00%   
IDEX Biometrics ASA competes with Issuer Direct, EGain, Research Solutions, CurrentC Power, and Agent Information; as well as few others. The company classifies itself under Technology sector and is part of Software—Application industry. Analyzing IDEX Biometrics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of IDEX Biometrics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of IDEX Biometrics competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.170.170.17
Details
Intrinsic
Valuation
LowRealHigh
0.140.140.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as IDEX Biometrics. Your research has to be compared to or analyzed against IDEX Biometrics' peers to derive any actionable benefits. When done correctly, IDEX Biometrics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IDEX Biometrics ASA.

IDEX Biometrics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IDEX Biometrics and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of IDEX and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of IDEX Biometrics ASA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NOGNW
+ 0.79
MIXT
MIXT
+ 0.62
ISDR
NOGNW
+ 0.59
ISDR
NOGNW
+ 0.45
EGAN
SWRM
+ 0.36
AKRFF
MIXT
+ 0.35
EGAN
  
High negative correlations   
AIFS
- 0.55
MIXT
AECX
- 0.51
MIXT
AIFS
- 0.42
NOGNW
NOGNW
- 0.42
AECX
AIFS
- 0.38
ISDR
AIFS
- 0.34
AKRFF

Risk-Adjusted Indicators

There is a big difference between IDEX Pink Sheet performing well and IDEX Biometrics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IDEX Biometrics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ISDR  2.74 (0.04) 0.01  0.10  2.83 
(3.16)
 8.57 
(4.71)
 19.72 
EGAN  2.71 (0.73) 0.00 (0.15) 0.00 
 0.00 
 5.62 
(7.25)
 18.26 
MIXT  2.00 (0.17) 0.00 (3.42) 0.00 
 0.00 
 3.52 
(3.34)
 12.12 
RSSS  1.70  0.25  0.11  0.47  1.57 
(2.29)
 4.60 
(3.32)
 8.98 
AKRFF  1.05  0.22  0.00 (0.07) 0.00 
 0.00 
 2.38 
 0.00 
 26.01 
AECX  12.45  3.32  0.06 (1.10) 13.28 
(61.67)
 66.67 
(43.48)
 150.00 
NOGNW  8.43  0.01  0.00  0.14  12.29 
(8.85)
 29.75 
(23.21)
 69.97 
AIFS  3.78  0.52  0.03  0.61  5.60 
(13.13)
 22.34 
(9.00)
 51.28 
CONMF  8.19  1.91  0.07 (1.17) 8.67 
(35.49)
 20.00 
(16.67)
 189.63 
SWRM  5.94  0.96  0.00  3.04  0.00 
 0.00 
 50.00 
(33.33)
 83.33 
All Fundamental Data

IDEX Biometrics Competitive Analysis

The better you understand IDEX Biometrics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IDEX Biometrics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IDEX Biometrics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IDXAF ISDR EGAN MIXT RSSS AKRFF AECX NOGNW AIFS CONMF
 0.00 
 0.17 
IDEX
 0.20 
 10.00 
Issuer
 3.90 
 5.33 
EGain
 4.72 
 6.88 
Mix
 1.46 
 3.47 
Research
 7.44 
 0.09 
Ackroo
 8.33 
 0.13 
CurrentC
 7.56 
 0.01 
Nogin
 8.00 
 1.35 
Agent
 0.00 
 0.15 
CoinSmart
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Slightly risky
Very steady
Slightly risky
Out of control
Out of control
Very steady
Abnormally volatile
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Good
Weak
OK
Very Weak
Modest
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Very Low
Dangerous
Low
Quite High
Above Average
Dangerous
Below Average
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Not Available
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Cautious Hold
Strong Sell
Not Rated
Strong Buy
Strong Sell
Strong Sell
Not Rated
Strong Sell
Not Rated
Current Ratio
7.85
4.31
1.68
1.75
1.4
1.16
N/A
0.25
1.58
1.29
Net Asset
42.13 M
65.15 M
127.85 M
176.56 M
41.86 M
8.95 M
N/A
74.93 M
N/A
83 M
Profit Margin
N/A
-0.0454
0.0645
0.0372
-0.0849
-0.45
N/A
-0.57
-0.0246
-0.85
EBITDA
(30.63 M)
5.38 M
12.7 M
13.25 M
66.73 K
(112.37 K)
N/A
(44.74 M)
(260.66 K)
(1.57 M)
Operating Margin
-8.78
0.0286
0.0234
0.0628
0.0545
-0.21
-5.91
-0.97
-0.0716
-0.15
Current Valuation
128.98 M
51.6 M
88.46 M
320.07 M
105.9 M
8.63 M
N/A
N/A
3.25 M
(39.49 M)
Price To Book
4.7
1.09
2.73
2.99
8.84
4.43
N/A
N/A
1.21
0.88
Retained Earnings
N/A
11.93 M
(323.66 M)
79.02 M
(26.31 M)
N/A
N/A
(82.29 M)
(1.04 M)
N/A
Current Asset
N/A
5.72 M
19.33 M
1.27 B
12.18 M
N/A
N/A
N/A
1.6 M
N/A
Five Year Return
N/A
N/A
N/A
1.96
N/A
N/A
N/A
N/A
N/A
N/A
Beta
2.25
0.77
0.44
0.82
0.57
1.67
20.63
0.3
0.56
N/A
Number Of Employees
92
136
539
1.03 K
145
15
4
213
9
45
Shares Outstanding
1.17 B
3.83 M
28.52 M
22.16 M
32.51 M
121.37 M
N/A
N/A
N/A
60.24 M
Cash Flow From Operations
(27.53 M)
3.06 M
12.45 M
21.95 M
3.55 M
29.12 K
(788.22 K)
(37.06 M)
1.09 M
161.04 K
Annual Yield
N/A
N/A
N/A
0.0166
N/A
N/A
N/A
N/A
0.0181
N/A
Total Debt
119 K
20.92 M
3.77 M
15.25 M
30.17 M
3.34 M
N/A
80.44 M
N/A
471.92 K
Return On Equity
-2.19
-0.0373
0.0973
0.0508
-0.4
-1.23
-0.48
N/A
-0.0339
-1.88
Z Score
N/A
N/A
N/A
14.5
N/A
0.6
N/A
-2.89
1.0
7.2
Return On Asset
-1.05
0.0059
0.0266
0.0514
-0.0151
-0.1
-0.16
-0.53
-0.0367
-0.0199
Book Value Per Share
0.015
9.2
1.96
0.2
0.39
0.01
4.74
-0.5
0.79
0.16
Number Of Shares Shorted
N/A
5.33 K
317.6 K
14.68 K
31.05 K
N/A
N/A
20.32 K
N/A
N/A
Current Liabilities
N/A
2.4 M
17.05 M
333.98 M
6.33 M
N/A
N/A
N/A
1.95 M
N/A
Total Asset
42.13 M
65.15 M
127.85 M
176.56 M
41.86 M
8.95 M
N/A
74.93 M
4.17 M
83 M
Debt To Equity
0.005
0.063
0.063
0.093
0.002
2.09
N/A
0.001
0.003
0.043
Short Ratio
N/A
0.72
6.99
0.09
1.27
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
13.0
9.5
12.0
5.12
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
0.01
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
12.48
42.28
56.73
46.79
42.15
17.57
N/A
N/A
0.76
N/A
Market Capitalization
93.31 M
38.34 M
152.03 M
322.44 M
112.82 M
6.38 M
N/A
N/A
2.82 M
5.93 M
Price To Earning
-15.06
49.11
35.13
18.82
-14.04
-0.85
N/A
N/A
22.75
N/A
Price To Earnings To Growth
N/A
N/A
0.99
0.81
2.1
N/A
N/A
N/A
N/A
N/A
Price To Sales
49.94
1.32
1.68
2.15
2.53
0.65
N/A
N/A
0.54
0.43
Net Income
(32.55 M)
766 K
7.78 M
4.52 M
(3.79 M)
(2.66 M)
(629.18 K)
(38.88 M)
1.27 K
(2.08 M)
Earnings Per Share
-0.035
-0.35
0.19
0.3
-0.07
-0.017
N/A
N/A
-0.019
N/A
Shares Owned By Insiders
21.25
21.53
35.17
6.15
24.02
38.36
N/A
N/A
N/A
46.04
Revenue
2.84 M
33.38 M
92.8 M
144.99 M
44.62 M
5.98 M
74.78 K
68.27 M
5.24 M
14.36 M
Working Capital
N/A
(1.15 M)
44.51 M
17.72 M
(3.18 M)
N/A
N/A
(18.49 M)
(354 K)
N/A
Cash And Equivalents
16.32 M
21.46 M
72.17 M
24.64 M
10.6 M
775.17 K
N/A
90.18 K
2.14 M
18.21 M
Cash Per Share
0.02
5.94
2.26
1.12
0.39
0.01
N/A
N/A
0.46
0.3
Gross Profit
1.59 M
17.83 M
70.7 M
91.44 M
14.7 M
5.27 M
(20.02 K)
N/A
3.39 M
10.75 M
Day Typical Price
0.17
9.91
5.27
6.76
3.44
0.091
0.15
0.0125
1.35
0.15
Accumulation Distribution
N/A
0.0299
0.0319
0.0552
0.04
N/A
0.28
0.0703
N/A
N/A
Market Facilitation Index
N/A
0.3
0.17
0.38
0.14
N/A
0.05
9.0E-4
N/A
N/A
Daily Balance Of Power
0.0
0.0667
1.176471
0.8158
0.3571
9.2 T
0.2
1.0
9.2 T
0.0
Period Momentum Indicator
N/A
0.02
0.2
0.31
0.05
0.0063
0.01
9.0E-4
0.1
N/A
Rate Of Daily Change
1.0
1.0
1.04
1.05
1.01
1.07
1.08
1.08
1.08
1.0
Day Median Price
0.17
9.87
5.25
6.7
3.43
0.091
0.16
0.0124
1.35
0.15
Price Action Indicator
N/A
0.14
0.19
0.34
0.065
0.0032
(0.02)
9.0E-4
0.05
N/A
Coefficient Of Variation
812.4
2464.21
(1,023)
(1,594)
632.84
4217.08
874.11
8433.47
1253.15
1227.25
Mean Deviation
3.36
2.74
2.71
2.0
1.7
1.05
12.45
8.43
3.78
8.19
Jensen Alpha
2.13
(0.04)
(0.73)
(0.17)
0.2514
0.218
3.32
0.0141
0.519
1.91
Total Risk Alpha
(0.62)
(0.50)
(1.04)
(0.59)
(0.03)
(0.55)
(1.38)
(2.03)
(0.74)
(1.82)
Sortino Ratio
N/A
0.0066
N/A
N/A
0.1122
N/A
0.0625
0.0011
0.0333
0.0679
Downside Variance
N/A
9.44
N/A
N/A
3.78
N/A
2080.6
208.06
251.81
547.72
Standard Deviation
13.85
3.89
3.91
2.53
2.25
3.76
26.12
13.0
8.34
21.2
Kurtosis
66.0
2.73
2.45
0.2369
0.1181
20.84
6.03
2.27
5.91
33.97
Potential Upside
N/A
8.57
5.62
3.52
4.6
2.38
66.67
29.75
22.34
20.0
Treynor Ratio
(0.50)
0.0991
(0.15)
(3.42)
0.4678
(0.07)
(1.10)
0.1414
0.6116
(1.17)
Maximum Drawdown
112.5
19.72
18.26
12.12
8.98
26.01
150.0
69.97
51.28
189.63
Variance
191.76
15.12
15.28
6.39
5.07
14.16
682.22
168.93
69.63
449.46
Market Risk Adjusted Performance
(0.49)
0.1091
(0.14)
(3.41)
0.4778
(0.06)
(1.09)
0.1514
0.6216
(1.16)
Risk Adjusted Performance
0.1035
0.0391
(0.07)
(0.04)
0.1274
0.0261
0.0972
0.0185
0.0701
0.0719
Skewness
8.12
1.36
(0.43)
0.1687
0.4206
(0.99)
1.84
0.4576
0.4707
4.91
Semi Deviation
N/A
2.83
N/A
N/A
1.57
N/A
13.28
12.29
5.6
8.67
Information Ratio
0.1132
0.0052
(0.13)
(0.12)
0.0969
(0.01)
0.1091
0.0013
0.0633
0.075
Value At Risk
N/A
(4.71)
(7.25)
(3.34)
(3.32)
N/A
(43.48)
(23.21)
(9.00)
(16.67)
Expected Short fall
N/A
(3.16)
N/A
N/A
(2.29)
N/A
(61.67)
(8.85)
(13.13)
(35.49)
Downside Deviation
N/A
3.07
N/A
N/A
1.94
N/A
45.61
14.42
15.87
23.4
Semi Variance
N/A
8.0
N/A
N/A
2.47
N/A
176.32
151.16
31.37
75.12

IDEX Biometrics Competition Performance Charts

Five steps to successful analysis of IDEX Biometrics Competition

IDEX Biometrics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by IDEX Biometrics ASA in relation to its competition. IDEX Biometrics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of IDEX Biometrics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IDEX Biometrics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to IDEX Biometrics ASA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IDEX Biometrics position

In addition to having IDEX Biometrics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in IDEX Pink Sheet

If you are still planning to invest in IDEX Biometrics ASA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IDEX Biometrics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY